CClinicalTrials.gg
CompletedNCT00260221VRHUpdated May 8, 2013

VRH Pain Reduction During Burn Wound Care and Physical Therapy

An interventional study of using VR hypnosis/distraction and audio hypnosis in Burn, sponsored by National Institute of General Medical Sciences (NIGMS). Completed at 1 site in United States. Open to participants aged 7 Years to 85 Years. Per ClinicalTrials.gov, last updated 2013-05-08.

Sponsored by National Institute of General Medical Sciences (NIGMS) · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
7 Years to 85 Years
Sex
All
01

Study summary

Using Virtual Reality Hypnosis to relief pain and anxiety for burn patients.

Read the detailed description

The purpose of the study is to examine whether there is more effective relief of pain and anxiety during wound care procedures in burn-injured patients that are treated with Virtual Reality Hypnosis with post-hypnotic suggestion.

02

Conditions studied

  • Burn

Browse trials for

Keywords

  • Virtual Reality Hypnosis
03

In context

Burns

719 studies on the registry are indexed under Burns; 145 are open to participants now.

This study's enrollment of 77 is above the median of 40 across 524 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

National Institute of General Medical Sciences (NIGMS) is the lead sponsor of 19 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age greater than or equal to 7 years
  • Able to complete subjective evaluations of pain
  • English-speaking
  • Not demonstrating delirium, psychosis, or any form of Organic Brain Disorder
  • Able to communicate orally

Exclusion criteria

Exclusion Criteria:

  • Age less than 7 years
  • Incapable of indicating subjective evaluation of pain
  • Non-English-speaking
  • Demonstrating delirium, psychosis, or Organic Brain Disorder
  • Unable to communicate verbally
  • Significant developmental disability
  • Extreme susceptibility to motion sickness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
77 participants (actual)

Study arms

  • Experimental
    1

    Arm one uses Virtual Reality Hypnosis post hypnotic suggestions to reduce pain durng wound care procedures.

    Behavioral: using VR hypnosis/distraction and audio hypnosis

  • Experimental
    2

    Arm two uses Virtual Reality distraction that is administered at times other than during burn care procedure to control for both for attention and high technology.

    Behavioral: using VR hypnosis/distraction and audio hypnosis

  • Experimental
    3

    Arm three use Audio administered Hypnosis without the visual technology.

    Behavioral: using VR hypnosis/distraction and audio hypnosis

Interventions

  • Behavioralusing VR hypnosis/distraction and audio hypnosis

    a between subject comparison using VR hypnosis and VR distraction and audio hypnosis for pain control

06

What researchers measure

Primary outcomes

  1. we use GRS, VAS, McGill,and nurse GRS to measure the pain.

    Time frame: once a day

07

Study locations

1 site
  • University of Washington; Harborview Medical Center
    Seattle, Washington 98104, United States
08

References and documents

Publications

  • Patterson DR, Tininenko JR, Schmidt AE, Sharar SR. Virtual reality hypnosis: a case report. Int J Clin Exp Hypn. 2004 Jan;52(1):27-38. doi: 10.1076/iceh.52.1.27.23925. PubMed 14768967 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00260221
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborators
National Institutes of Health (NIH)
Responsible party
David R. Patterson (PhD. ABPP. Professor, National Institute of General Medical Sciences (NIGMS)) — Principal investigator
First posted
Dec 1, 2005
Start date
Jan 2002
Primary completion
Jan 2011
Completion
Nov 2011
Last update
May 8, 2013

Study contacts

David R. Patterson, Ph.D.
principal investigator · University of Washington

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion